Diligence memo · auto-generated · as of July 2, 2026
Global Pharm Holdings Group, Inc.
Global Pharm Holdings Group, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Global Pharm Holdings Group, Inc. operates in Pharmaceuticals, based in FUTIAN DISTRICT, SHENZHEN,.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Global Pharm Holdings Group, Inc. has raised $66M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $42M on 2011-08-01.
Most recent recorded round closed around 2011-09-21.
Valuation (modeled)modeled
Provath models Global Pharm Holdings Group, Inc. at approximately $351M (range $32M–$925M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.20× the median modeled value of Series C Pharmaceuticals companies in 2010–2012 (12 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 1 months.
Last raise 14.8 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 85% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 77% of those peers.
Closest niche peers: Acadia Pharmaceuticals Inc, Agios Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, PCAS Patient Care Automation Services Inc., China Medicine Corp.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.